Mukka Proteins Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹508.9 Cr (+108% YoY), EBITDA ₹50.1 Cr (9.9% margin), PAT ₹17.7 Cr (3.5%). Targets ₹3,000+ Cr revenue by FY30.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
55 announcements with these filters
Q2 FY27 consolidated revenue ₹508.9 Cr (+108% YoY), EBITDA ₹50.1 Cr (9.9% margin), PAT ₹17.7 Cr (3.5%). Targets ₹3,000+ Cr revenue by FY30.
Mukka Proteins reported Q2 FY27 revenue up 108% YoY to Rs.5,088.70 Mn. The Oman facility began commercial production, adding 37,200 MTPA of capacity.
Mukka Proteins' board approved revised terms to acquire 85,200 equity shares, a 46% stake, in Swachha Eco Solutions for up to Rs 2.13 Crore. The unlisted waste-management company is not a related party.
Mukka Proteins filed its quarterly statement of deviation for funds raised through a preferential warrant issue, reporting no deviation. Utilisation of Rs. 11.75 Crore against the working capital object is shown for the quarter ended September 2026.
Mukka Proteins Ltd reported revenue from operations of ₹508.9 Cr (+108.1% YoY) and net profit of ₹17.7 Cr (+156.5% YoY) for Q2 FY27.
Mukka Proteins intimated a board meeting on 07 Nov 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closure is also disclosed.
Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Mukka Proteins Limited announced its subsidiary, United Gulf Fishery Products LLC, has commenced commercial production in Oman. The facility will produce fish meal and oil.
Mukka Proteins Limited approved a corporate guarantee and SBLC worth Rs. 73.58 Crore for its subsidiary in Oman. The security supports credit facilities from HDFC Bank.
CARE Ratings has reaffirmed the credit ratings of Mukka Proteins Ltd at CARE BBB-; Stable / CARE A3.
CARE Ratings reaffirmed the credit ratings for Mukka Proteins Ltd's bank facilities totaling ₹495 Crore and revised the outlook from Negative to Stable.
Mukka Proteins received a USDA NOP attestation from ECOCERT for its organic fertilizer. The certification supports marketability in US organic farming markets through March 2028.
Mukka Proteins Limited announced a delay in acquiring a 51% stake in Aqua Marine for Rs. 15 Crore. The completion date is revised to January 31, 2027.
Mukka Proteins Limited announced the re-appointment of six directors to its board, including independent and executive members, each for a five-year term.
Mukka Proteins Limited held its 16th Annual General Meeting on September 10, 2026. The meeting covered financial adoption, director re-appointments, and other routine business.
Mukka Proteins allot 2 Crore convertible warrants to 15 non-promoter investors at Rs. 23.50, raising Rs. 47 Crore. Warrants convert to one equity share in 18 months.
Mukka Proteins received an 'EU - Inputs Attestation' from ECOCERT S.A.S. for its 'Eco Sphere Organic Fertilizer', validating its suitability for use in organic farming.
Mukka Proteins received an EU-Inputs Attestation from ECOCERT S.A.S., France, for its Eco Sphere Organic Fertilizer. This confirms suitability for organic farming, enhancing product marketability.
Mukka Proteins Limited will acquire a 16.77% stake in Shipwaves Online Limited for ₹13.19 Crore. This strategic investment aims to leverage synergies in the logistics sector.
Mukka Proteins is scaling its Bengaluru bioconversion capacity to process 1,000 tonnes per day of organic waste by December 2027. The expansion targets high-value insect protein and oils.
Mukka Proteins Ltd received exchange approval for its preferential issue of 2 crore convertible warrants at ₹23.50 each, amounting to ₹47 crore.
Mukka Proteins corrected the total consideration for its 25.98% stake acquisition in Swachha Eco Solutions, revising the amount to ₹0.66 Crore due to a calculation error.
Mukka Proteins shared a weblink with shareholders lacking registered email addresses to access the FY 2025-26 Annual Report and notice for the upcoming AGM.
Mukka Proteins Limited announced its 16th Annual General Meeting will be held on September 10, 2026. The meeting will be conducted via video conferencing.
Mukka Proteins reported strong Q1 FY27 results, driven by favorable fishmeal pricing and improved realizations as it transitions into an integrated animal protein and sustainability platform.
Mukka Proteins Limited reported a 186.7% YoY revenue growth to ₹489.65 Crore for Q1 FY27. Consolidated PAT surged 1,072.5% to ₹18.63 Crore during the period.
Mukka Proteins Limited is acquiring a 25.98% stake in Swachha Eco Solutions Private Limited for ₹0.65 Crore. This strategic investment aims to expand its waste management segment.
Mukka Proteins Limited has decided not to proceed with its previously approved ₹75 Crore Non-Convertible Debentures (NCD) issuance. The Board has formally rescinded the approval.
Mukka Proteins Limited approved the re-appointment of six directors, including the Managing Director, CFO, and COO, for a second five-year term starting January 2027.